Randomised controlled trial. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: Trial design and protocol (CONSTRUCT)-Reference-Cited by-同舟云学术

Randomised controlled trial. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: Trial design and protocol (CONSTRUCT)

Published:2014-04 Issue:4 Volume:4 Page:e005091
ISSN:2044-6055
Container-title:BMJ Open
language:en
Short-container-title:BMJ Open

Author:

Seagrove Anne C,Alam M Fasihul,Alrubaiy Laith,Cheung Wai-Yee,Clement Clare,Cohen David,Grey Michelle,Hilton Mike,Hutchings Hayley,Morgan Jayne,Rapport Frances,Roberts Stephen E,Russell Daphne,Russell Ian,Thomas Linzi,Thorne Kymberley,Watkins Alan,Williams John G

Publisher

BMJ

Subject

General Medicine

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pragmatic Trial Design to Compare Real-world Effectiveness of Different Treatments for Inflammatory Bowel Diseases: The PRACTICE-IBD European Consensus;Journal of Crohn's and Colitis;2024-02-17

2. Validation of the ACE [Albumin, CRP, and Endoscopy] Index in Acute Colitis: Analysis of the CONSTRUCT dataset;Journal of Crohn's and Colitis;2023-08-24

3. Infliximab versus ciclosporin in steroid resistant acute severe ulcerative colitis: a model-based cost-utility analysis of data from CONSTRUCT pragmatic trial;BMC Health Services Research;2023-03-08

4. Quality of Life in Patients with Acute Severe Ulcerative Colitis: Long-Term Follow-Up Results from the CONSTRUCT Trial;Journal of Personalized Medicine;2022-12-09

5. Further Validation of the Crohn’s and Ulcerative Colitis Questionnaire-32 (CUCQ-32) to Measure the Quality of Life in Patients Treated with Biologics Therapy;Clinics and Practice;2022-06-10